Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing

Nat Commun. 2020 Jan 21;11(1):400. doi: 10.1038/s41467-019-14253-4.

Abstract

Circulating cell-free mRNA (cf-mRNA) holds great promise as a non-invasive diagnostic biomarker. However, cf-mRNA composition and its potential clinical applications remain largely unexplored. Here we show, using Next Generation Sequencing-based profiling, that cf-mRNA is enriched in transcripts derived from the bone marrow compared to circulating cells. Further, longitudinal studies involving bone marrow ablation followed by hematopoietic stem cell transplantation in multiple myeloma and acute myeloid leukemia patients indicate that cf-mRNA levels reflect the transcriptional activity of bone marrow-resident hematopoietic lineages during bone marrow reconstitution. Mechanistically, stimulation of specific bone marrow cell populations in vivo using growth factor pharmacotherapy show that cf-mRNA reflects dynamic functional changes over time associated with cellular activity. Our results shed light on the biology of the circulating transcriptome and highlight the potential utility of cf-mRNA to non-invasively monitor bone marrow involved pathologies.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / isolation & purification*
  • Bone Marrow / drug effects
  • Bone Marrow / pathology*
  • Cell-Free Nucleic Acids / blood
  • Cell-Free Nucleic Acids / genetics
  • Cell-Free Nucleic Acids / isolation & purification*
  • Feasibility Studies
  • Gene Expression Profiling / methods
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Hematopoietic Stem Cell Transplantation / methods
  • Hematopoietic Stem Cells / drug effects
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / therapy
  • Longitudinal Studies
  • Middle Aged
  • Multiple Myeloma / blood
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy
  • RNA, Messenger / blood
  • RNA, Messenger / genetics
  • RNA, Messenger / isolation & purification*
  • Sequence Analysis, RNA / methods
  • Treatment Outcome
  • Young Adult

Substances

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids
  • RNA, Messenger
  • Granulocyte Colony-Stimulating Factor